HUTCHMED (China)
Open
$13.40
Prev. Close
$13.40
High
$13.40
Low
$13.35
Market Snapshot
$2.33B
-15.3
2.00
$3.14B
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,796 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.
emptyResult
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,796 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.
Recently from Cashu
HUTCHMED (China) Enhances Efficiency by Adopting Advanced HCM Platforms and Automation Trends
HUTCHMED (China) Leverages HCM Platform Trends to Enhance Operational Efficiency As the landscape of human capital management (HCM) continues to evolve, HUTCHMED (China) positions itself to capitalize…
HUTCHMED Enhances Workforce Management with AI-Driven HR Solutions and Integrated Platforms
Modernizing Workforce Dynamics: HUTCHMED's Integration of AI and HR Solutions In the rapidly evolving landscape of human capital management (HCM), small and midsized businesses are increasingly priori…
Future of HCM: Integration and AI Strategies for Enhanced Workforce Management
Integrating Workforce Strategies: The Future of Human Capital Management As the landscape of Human Capital Management (HCM) evolves, leaders in the market, including ADP Lyric HCM, Dayforce, and Oracl…
HUTCHMED (China) Enhances Workforce Strategy Through Evolving Human Capital Management Solutions
Evolving Human Capital Management Solutions: A Catalyst for Workforce Optimization in Biotech HUTCHMED (China), a key player in the biopharmaceutical field, can draw significant insights from recent t…